HUTCHMED (China) (HCM) Income from Continuing Operations (2015 - 2021)
HUTCHMED (China)'s (HCM) quarterly Income from Continuing Operations came in at 264251000.0 in Q4 2021, down 128.72% on a QoQ basis from 115534000.0 in Q2 2021.
HUTCHMED (China) (HCM) Income from Continuing Operations (2015 - 2021) Analysis & Trends
HUTCHMED (China) (HCM) has 6 years of Income from Continuing Operations data on file, last reported at 264251000.0 in Q4 2021.
- On a quarterly basis, Income from Continuing Operations changed N/A year-over-year to 264251000.0 in Q4 2021; TTM through Dec 2021 was 424974000.0, a N/A change from a year earlier, with the FY2025 full-year figure at 64438434.71, up 836.98% from the prior year.
- Income from Continuing Operations for Q4 2021 stood at 264251000.0, down from 115534000.0 in the prior quarter.
- Over the last five years, Income from Continuing Operations for HCM reached as high as 70120000.0 in Q2 2018 and fell as low as 264251000.0 in Q4 2021.
- Historically, Income from Continuing Operations has averaged 31537230.77 across 4 years, with a median of 22305000.0 in 2018.
- Across the five-year window, Income from Continuing Operations surged 250.63% in 2019 and plunged 832.2% in 2021, its largest moves.
- Year by year, Income from Continuing Operations stood at 22093000.0 in 2018, then soared by 183.6% to 62655000.0 in 2019, then tumbled by 74.82% to 15779000.0 in 2020, then sank by 1774.7% to 264251000.0 in 2021.
- Per Business Quant data, the three most recent Income from Continuing Operations figures were 264251000.0 in Q4 2021, 115534000.0 in Q2 2021, and 60968000.0 in Q1 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 370.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -3.58 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 274.90 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 57.00 Mn |
| 10 | HUTCHMED (China) | 9.45 Bn | 9.45 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -264.25 Mn |
| Jun 30, 2021 | -115.53 Mn |
| Mar 31, 2021 | -60.97 Mn |
| Jun 30, 2020 | 15.78 Mn |
| Mar 31, 2020 | -30.28 Mn |
| Dec 31, 2019 | 62.66 Mn |
| Sep 30, 2019 | -34.24 Mn |
| Jun 30, 2019 | -99.44 Mn |
| Mar 31, 2019 | 33.60 Mn |
| Dec 31, 2018 | 22.09 Mn |
| Sep 30, 2018 | 12.78 Mn |
| Jun 30, 2018 | 70.12 Mn |
| Mar 31, 2018 | -22.31 Mn |
| Jun 30, 2016 | 29.56 Mn |
| Jun 30, 2015 | 23.49 Mn |